HAE stock forecast
Our latest prediction for Haemonetics Corp.'s stock price was made on the Oct. 9, 2019 when the stock price was at 124.61$.
In the short term (2weeks), HAE's stock price should outperform the market by 0.57%. During that period the price should oscillate between -4.23% and +5.17%.
In the medium term (3months), HAE's stock price should outperform the market by 1.23%. During that period the price should oscillate between -10.81% and +14.84%.Get email alerts
About Haemonetics Corp.
Haemonetics Corp. engages in the development and distribution of hematology products and solutions. It operates through the following geographical segments: Japan, EMEA (Europe, the Middle East, and Africa), North America Plasma, and All Other. Its products include surgical and diagnostic devices, blood and plasma center devices, blood center software, hospital software, and plasma center software. The company was founded by Allen Latham, Jr. in 1971 and is headquartered in Braintree, MA.
At the moment the company generates 988M USD in revenues.
On its last earning announcement, the company reported a profit of 1.30$ per share.
The book value per share is 13.04$
Three months stock forecastOct. 9, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|